Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
/R E P E A T -- Héma-Québec invites you to celebrate the 10th anniversary of its Gatineau Centre by making a donation!/
18 Apr 2026
PR Newswire Association LLC.
World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care."
17 Apr 2026
PR Newswire Association LLC.
GREY WOLF ANIMAL HEALTH REPORTS FOURTH QUARTER AND YEAR END 2025 FINANCIAL RESULTS
17 Apr 2026
GlobeNewswire
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
17 Apr 2026
PR Newswire Association LLC.
Bracco Receives Health Canada Approval for VUEWAY® injection (gadopiclenol), Advancing Lower-Dose MRI Contrast Imaging
17 Apr 2026
GlobeNewswire
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
17 Apr 2026
PR Newswire Association LLC.
VVT Med Announces Application for Management Cease Trade Order
17 Apr 2026
PR Newswire Association LLC.
The Week in Canadian Press Releases: 10 Stories You Need to See
17 Apr 2026
PR Newswire Association LLC.
Nurses at Markham Stouffville Hospital Vote to Join Ontario Nurses' Association in Historic Union Drive
17 Apr 2026
PR Newswire Association LLC.
Xtalks Named Media Partner for the Toronto Life Sciences and Biotech Summit
16 Apr 2026
GlobeNewswire
AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP
16 Apr 2026
GlobeNewswire
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
16 Apr 2026
GlobeNewswire
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
16 Apr 2026
GlobeNewswire
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
16 Apr 2026
PR Newswire Association LLC.
ZYUS Life Sciences Announces Completion of the Final Study Visit by the Last Patient in Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug
16 Apr 2026
PR Newswire Association LLC.
MRD-Driven Oncology Trials: Regulatory, Clinical and Pharmacology Considerations, Upcoming Webinar Hosted by Xtalks
16 Apr 2026
PR Newswire Association LLC.
Héma-Québec invites you to celebrate the 10th anniversary of its Gatineau Centre by making a donation!
16 Apr 2026
PR Newswire Association LLC.
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
16 Apr 2026
PR Newswire Association LLC.
Bold Therapeutics' Clinical-Stage Anticancer Agent BOLD-100 Demonstrates Protective Effects Against Chemotherapy-Induced Peripheral Neuropathy
16 Apr 2026
PR Newswire Association LLC.
MedExpress Launches in Canada with Appointment of Dr. Ashley White as Medical Lead
16 Apr 2026
GlobeNewswire
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
16 Apr 2026
GlobeNewswire
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression
15 Apr 2026
GlobeNewswire
Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
15 Apr 2026
GlobeNewswire
Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
15 Apr 2026
GlobeNewswire
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
15 Apr 2026
Upcoming Events All Events
- April 2026
- Seattle: Life Science Innovation Northwest 2026
- Leipzig: German Biotech Days
- Shanghai: ChinaBio® Partnering Forum